The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)
NCT03851887
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
COMBINATION_PRODUCT:
TAI combine SBRT
Sponsor
Sun Yat-sen University